What is the generic name?

PITAVASTATIN MAGNESIUM

What is the Trade Name for PITAVASTATIN MAGNESIUM?

ZYPITAMAG

What are the Indications for PITAVASTATIN MAGNESIUM?

• 1 INDICATIONS AND USAGE ZYPITAMAG is indicated as an adjunctive therapy to diet in adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C). Limitations of Use The effect of ZYPITAMAG on cardiovascular morbidity and mortality has not been determined. Pediatric use information is approved for Kowa Co Ltd‚Äôs LIVALO (pitavastatin) tablets. However, due to Kowa Co Ltd‚Äôs marketing exclusivity rights, this drug product is not labeled with that information. ZYPITAMAG is an HMG-CoA reductase inhibitor indicated as an adjunctive therapy to diet in adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C) Limitations of Use : The effect of ZYPITAMAG on cardiovascular morbidity and mortality has not been determined.

References: https://open.fda.gov/